Concepedia

Author

Mario Presti

Copenhagen University HospitalORCID

Also Known As

Mario Presti

52

Publications

296

Citations

9

H-Index

24

Concepts

All Affiliations

Copenhagen University HospitalUniversity of CataniaCentro Neurolesi Bonino PulejoDanish Cancer SocietyAarhus University
MP

About

Mario Presti is an author at Copenhagen University Hospital specializing in immunology, immunotherapy, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

72

2

Cell Biology

3

3

72

3

Immunology

3

3

72

4

Engineering

1

1

26

5

Autoimmune Disease

1

1

32

Mario Presti

×

8

Publications

221

Citations

8

H-Index

YearCitations

Overexpression of macrophage migration inhibitory factor and functionally‑related genes, D‑DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma

Mario Presti, Emanuela Mazzon, Maria Sofia Basile,

Oncology Letters

2018

67

Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis

Salvo Danilo Lombardo, Emanuela Mazzon, Maria Sofia Basile,

International Journal of Molecular Sciences

2019

32

Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma

Aishwarya Gokuldass, Arianna Draghi, Krisztián Papp,

Cancers

2020

28

Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling

Salvo Danilo Lombardo, Mario Presti, Katia Mangano,

Brain Sciences

2019

26

Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens

Arianna Draghi, Christopher A. Chamberlain, Shawez Khan,

Frontiers in Immunology

2021

24

Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Arianna Draghi, Mario Presti, Agnete W.P. Jensen,

Clinical Cancer Research

2023

16

The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro

Mario Presti, Marie Christine Wulff Westergaard, Arianna Draghi,

Cancer Immunology Immunotherapy

2020

14

Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy

Morten Nielsen, Mario Presti, Zsófia Sztupinszki,

Cancer Immunology Research

2022

14

Page 1